Page 43 - Confidence Interval News Today

Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline today announce positive efficacy and safety results from the global Phase 3 placebo-controlled efficacy study of Medicago’s plant-based COVID-19 vaccine candidate in combination with GSK’s pandemic adjuvant, conducted in over 24,000 subjects, adults 18 years and above, across six countries.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Primary endpoints and secondary endpoints for which data are available were met in trial dominated by COVID-19 variants Efficacy demonstrated against all variants seen in the study, including 75.3%

Rewards of $25 to people getting a COVID-19 shot or for drivers who take someone to get a first dose had positive effects in a North Carolina pilot study.

Problems with executive function and recall are appearing even in younger cohorts. Effects will have significant repercussions on quality of life, work productivity, and healthcare costs, experts warn.

Approval is based on positive results from the Phase 3 CheckMate -649 trial Opdivo plus chemotherapy is the first treatment regimen to demonstrate superior overall survival and progression-free survival compared to chemotherapy alone in this patient population Bristol Myers Squibb Receives European Commission Approval for Opdivo  + Chemotherapy for Patients with HER2 Negative, Advanced or Metastatic Gastric, ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Patient selection using DRP score of 50% resulted in a median survival of 15.0 monthPatient selection using DRP score of 67% resulted in a median survival of 20.6 months Press Release Hørsholm

January. thats on the left-hand side. are those the same people the next month? >> no. so, the people who got vaccinated in january -- people who finished their vaccination in january are on the left. people who finished their vaccination in february, the next one. and then, march. so what you would expect is that it would be gradually going up, right? the closer -- the -- the -- the more -- the further you are from your vaccination, you should have less protection. so january should be the lowe...

Newcrest Mining Limited PNGX: NCM) is pleased to announce that the Newcrest Board has approved the Cadia PC1-2 Pre-Feasibility Study enabling the commencement of the Feasibility Stage and Early Works Program. The Study updates and defines a significant portion of Cadia's future mine plan, with the development of PC1-2 accounting for ~20% of Cadia's current Ore Reserves. The approved commencement of the Early Works ...